226 related articles for article (PubMed ID: 31401175)
1. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
[No Abstract] [Full Text] [Related]
2. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
[TBL] [Abstract][Full Text] [Related]
4. Financial incentives and the prescription of newer vaccines by doctors in India.
Lodha R; Bhargava A
Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
[No Abstract] [Full Text] [Related]
5. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
Checketts JX; Sims MT; Vassar M
JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
[TBL] [Abstract][Full Text] [Related]
6. Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.
Holloway RG; Mooney CJ; Getchius TS; Edlund WS; Miyasaki JO
Neurology; 2008 Jul; 71(1):57-63. PubMed ID: 18591506
[TBL] [Abstract][Full Text] [Related]
7. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
Frank R
Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
[No Abstract] [Full Text] [Related]
8. The impact of disclosing financial ties in research and clinical care: a systematic review.
Licurse A; Barber E; Joffe S; Gross C
Arch Intern Med; 2010 Apr; 170(8):675-82. PubMed ID: 20421551
[TBL] [Abstract][Full Text] [Related]
9. Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan.
Sawano T; Ozaki A; Saito H; Shimada Y; Tanimoto T
JAMA Netw Open; 2019 May; 2(5):e193817. PubMed ID: 31099864
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension.
Senoo Y; Saito H; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
Medicine (Baltimore); 2021 Mar; 100(12):e24816. PubMed ID: 33761642
[TBL] [Abstract][Full Text] [Related]
11. Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.
Yamamoto K; Murayama A; Ozaki A; Saito H; Sawano T; Tanimoto T
Int Urogynecol J; 2021 Feb; 32(2):443-451. PubMed ID: 33151353
[TBL] [Abstract][Full Text] [Related]
12. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines.
Murayama A; Kamamoto S; Murata N; Yamasaki R; Yamada K; Yamashita E; Saito H; Tanimoto T; Ozaki A
J Gastroenterol Hepatol; 2023 Apr; 38(4):565-573. PubMed ID: 36518089
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
Li DG; Singer S; Mostaghimi A
JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
[TBL] [Abstract][Full Text] [Related]
15. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
Insel TR
JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407
[No Abstract] [Full Text] [Related]
16. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
Choudhry NK; Stelfox HT; Detsky AS
JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700
[TBL] [Abstract][Full Text] [Related]
17. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan.
Murayama A; Kugo H; Senoo Y
BMJ Open; 2024 Jun; 14(6):e086396. PubMed ID: 38908845
[TBL] [Abstract][Full Text] [Related]
19. Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
Grindal AW; Khan R; Scaffidi MA; Rumman A; Grover SC
Inflamm Bowel Dis; 2019 Mar; 25(4):642-645. PubMed ID: 30295831
[TBL] [Abstract][Full Text] [Related]
20. Effect of financial relationships on the behaviors of health care professionals: a review of the evidence.
Robertson C; Rose S; Kesselheim AS
J Law Med Ethics; 2012; 40(3):452-66. PubMed ID: 23061573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
